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ABSTRACT
INTRODUCTION: According to the Centers for Disease Control and Prevention, cardiac and
pulmonary disease consistently rank on the top leading causes of death in the United States.
Therefore, the different pathologies of the heart and lungs are studied extensively in the medical
community. Current research hints at the possible association between the lymphatic system's
dysfunction and cardiopulmonary disease's pathological progression. However, the effect of
cardiopulmonary disease on the lymph nodes is not well known. A better understanding of the
possible pathological changes to the lymphatic system associated with cardiopulmonary disease
could help guide medical interventions.
OBJECTIVE: This study aims to investigate the effect of cardiopulmonary disease on lymph
node size and structure.
METHODS: Cadaveric dissections to quantify lymph nodes were performed on 9 cadavers at
Philadelphia College of Osteopathic Medicine Georgia Campus. The demographics of the
cadavers are 6 female, 3 male, 8 Caucasian, 1 Indian, with an age range of 58-95 with a mean of
70. The study utilized anatomical landmarks to identify and extract lymph nodes. The cadavers
were dissected for lumbar, common iliac, internal iliac, external iliac, superficial inguinal, deep
inguinal, pulmonary, pectoral, parasternal, infraclavicular, central, humeral, subscapular, anterior
neck, lateral neck, and cardiac lymph nodes. Cadavers were separated into two groups based on
inclusion criteria for cardiopulmonary disease. Inclusion criteria included respiratory failure,
atherosclerosis heart disease of native coronary artery, and organic heart disease.
RESULTS: First, the team examined to see if there was a difference in the number of lymph
nodes found per different regions of the body when comparing the cardiopulmonary group
versus non-cardiopulmonary group. Any P value of less than 0.05 was deemed significant.
Mann-Whitney U test between cardiopulmonary group versus non-cardiopulmonary group
yielded a P value of 0.1035. Next, an assessment of the distribution of two-dimensional area of
lower body regions and upper body regions were done. Deep Inguinal region had a P-value of
0.0146 for one tailed test and internal iliac region had a P-value of 0.0191 for one tailed test. Pvalue for pectoral region was 0.0111 for a one tailed test. All other regions were not statistically
significant in their difference. Lastly, qualitative analysis of lymph node histology between
diseased states did not yield any conclusive differences.
CONCLUSION: Increase in two-dimensional area of deep inguinal, pectoral, and internal iliac
lymph nodes suggest a possible relationship between cardiopulmonary disease state and
lymphatic changes.
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INTRODUCTION
The Lymphatic System

The lymphatic system is a specialized network of tissue and vessels that plays a role in
fluid homeostasis, host cell immune response, and lipid absorption (18, 34). The lymphatic
system's function is to remove harmful metabolites created as a by-product of metabolism,
provide an optimal environment for tissue functioning by removing fluids from the tissue, and
eliminate pathogens deemed harmful to the body (4). The lymphatic system provides optimal
conditions for tissue functioning and health by maintaining interstitial fluid and particulate
balance; to include water, large molecules, lipids, antigens, immune cells, and other components
in the interstitial spaces (18).
The lymphatic system has two components concerning host immune response: primary
lymphoid organs and secondary lymphoid tissues. The primary lymphoid organs deal with
developing competent lymphocytes and dispersing them, while the secondary lymphoid tissues
position lymphocytes at strategic locations to interact with foreign antigens entering the body
(10). Thus, secondary lymphoid tissue focuses on optimizing cellular interaction between foreign
antigens and host immune cells to propagate the efficient removal of potential pathogens, while
primary lymphoid organs focus on developing lymphocytes to distribute for the host immune
system (39). In addition to the lymphatic system’s role in fluid homeostasis and immune
response, recent findings highlight the importance of the lymphatic system’s role in lipid
absorption in the small intestines (4, 23). Dietary lipids, once inside the small intestines, are
repackaged by enterocytes resulting in the formation of chylomicrons that are loaded with
triacylglycerol. Each intestinal villus has a single lymphatic capillary in the middle that takes up
interstitial fluid as well as the chylomicrons. The lymphatic fluid, or lymph, is thus formed and is
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then directed to the submucosal and mesenteric collecting lymphatic vessels. Eventually, lymph
flows to mesenteric lymph nodes and the thoracic duct which ultimately returns it to the blood
circulation (23). A study utilizing functional inactivation of a single allele of Prox1 gene, touted
to be important for lymphatic vascular development, confirmed the vital role of lymphatics in
lipid homeostasis by showing what happens when the lymphatic system’s role is compromised
(12). The study revealed abnormal lymph leakage in Prox1 heterozygous mice suggesting a link
between lymphatic dysfunction and adult-onset obesity (12). This abnormal lymphatic vascular
development characterized by mispattern, or ruptures, led to leakage of lymph. The leakage
resulted in adult-onset obesity in Prox1 heterozygous mice compared to the control (12). The
accumulation of fat in the subcutaneous and intra-abdominal region was evidently the cause of
increase in weight. Conclusively, this supported the importance of lymphatic system’s role in
lipid absorption in the small intestines.
The primary lymphoid organs consist of bone marrow and the thymus. The primary
lymphoid organs are where de novo synthesis of lymphocytes occurs (10). Bone marrow is the
site for the development of B lymphocytes and T lymphocytes with B lymphocytes maturing at
this location. The T lymphocytes migrate from bone marrow to the thymus where they
differentiate into mature T lymphocytes. While the primary lymphoid organs are vital in the
development of immunocompetent naïve lymphocytes, the secondary lymphoid tissues are just
as important. They are strategic sites found throughout the body where pathogens might enter. It
is at this location that a cellular interaction between foreign antigens and host immune cells
occur. This maximizes the body’s defense against foreign antigens entering the body. The
secondary lymphoid tissues consist of the spleen, lymph nodes, and mucosa-associated lymphoid
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tissue: tonsils, bronchial-associated lymphoid tissue, gut-associated lymphoid tissue, and Peyer's
patches (10).
The Lymphatic Vasculature

The lymphatic network consists of five parts: the initial lymphatics, pre-collectors,
collecting vessels, lymph nodes, and lymphatic trunks (33). The lymphatic system is a one-way
open system, as compared to the two-way closed circulatory system. The lymphatic capillaries,
or initial lymphatics, are highly branched and open-ended, allowing the lymphatic system to
clear excess water, large molecules, lipids, antigens, immune cells, and particulate matter from
interstitial spaces (33). The particles and fluids drained by the lymphatic system are also known
as interstitial fluid. The lymphatic capillaries are composed of a discontinuous lymphatic
endothelial cell basement membrane with specialized intercellular junctions called button
junctions and elastic anchoring filaments connecting to the surrounding connective tissue (3).
This forms the inlet valves between the lymphatic endothelial cells and creates a route to which
large molecules, proteins, and foreign particles in the interstitial spaces enter the lymphatic
system. Hence, the large molecules, proteins, and foreign particles that could not enter back into
the circulatory system via the venous end due to size restriction and the endothelial glycocalyx
can do so through the lymphatic system. Once the fluids and particles collected from interstitial
spaces enter the initial lymphatics, it becomes lymphatic fluid, and it flows to the pre-collectors
and collecting vessels. Unlike the initial lymphatics, the pre-collectors, and collectors both
contain smooth muscle cells, and bicuspid valves to prevent lymph backflow (33). The precollectors are more like conduit vessels between the initial and collecting vessels, and thus have
sporadic muscle cells and a rudimentary valve. In general, lymph can flow in one direction away
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from the initial clearing site of the interstitial space. The collectors, or collecting vessels, are
more robust vessel with higher smooth muscle cell coverage with complete basement membrane.
It has more frequent valves preventing backflow of lymph and are the main workers for the
lymphatic system to propel the lymph up against gravity. The lymph passes through lymph nodes
along the way to the lymphatic trunks. The efferent vein of each lymph node is the first place the
fluid and particles are able to join the venous system. The remaining fluid and particles continue
to travel in the lymphatic system via the efferent collectors eventually entering lymphatic trunks,
of which the largest is the thoracic duct (4). The thoracic duct and right lymphatic duct empty
into the venous system at the venous angle with the subclavian and jugular veins (4, 33). Lastly,
the segments of collecting vessels between valves are called lymphangions. This is a contractile
unit capable of contracting independently or with surrounding lymphangions (33, 3). Other
external factors can also influence the lymphangion's pumping, including surrounding muscle
contractions, massage, temperature, and the autonomic nervous system.
The Lymphatic Drainage Mechanism

This drainage pathway is possible because of the interaction between hydrostatic and
oncotic pressures in the capillaries, tissues, and lymphatics. Any fluid or substances from the
capillaries not fully utilized in the tissues will enter the initial lymphatics and become lymphatic
fluid (33, 21). As blood passes through the capillary system, plasma fluids and proteins leak out
due to hydrostatic pressure (33, 21). The leakage of proteins from the capillary system into the
interstitial spaces increases interstitial oncotic pressure, resulting in fluids leaving the capillaries
to the interstitial spaces. While the previous notion was that most of the fluid lost could return
via the venous end of the capillary system, this has been revised due to the endothelial
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glycocalyx finding, a hydrophobic network of glycoprotein and proteoglycans, preventing any
fluid from entering the venous end of capillaries (19). The estimated net leakage is about 8 liters
per day (19). The lymphatic system is a clever system that addresses returning this normal net
leakage while combatting foreign pathogens. It also returns large molecules into the circulatory
system that could not have returned otherwise.
Factors affecting the lymphatic system

To understand how lymphatic changes may impact cardiopulmonary pathological states
and vice versa, the factors that determine lymphatic system function needs examining. Some
studies suggest a relationship between lymphatic failure and kidney failure (26, 13). The
reasoning is the lymphatic system's failure to drain excess fluid properly causes an increased
hydrostatic pressure, which can indirectly lead to damaging kidney structure via pulmonary
fibrosis. Seeing how the cardiopulmonary system also shares the same conduit as the renal
systems, the increased hydrostatic pressure due to lymphatic failure may also be associated with
cardiopulmonary failure. A study utilizing a chronic pulmonary artery banded rat model shows
the effect of myocardial edema on myocardial fibrosis development (8). While the exact
mechanism is unknown, it raises the possibility for increased hydrostatic pressure due to
lymphatic drainage failure as a potential reason for the development of fibrosis, leading to
cardiac dysfunction. In both circumstances mentioned before, inflammation is triggered by the
increased hydrostatic pressure from edema, which also results in the damaging of tissue and
vessels. This results in the repair mechanism and buildup of collagen at the site of injury. If
prolonged for a period of time, the natural repair cycle continues and fibrosis can occur,
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replacing healthy tissue or vessels, unintentionally replacing the structure to a less flexible one
when compared to before.
Additionally, Brakenhielm and colleagues discuss the lymphatic system's role in heart
health in general and outlined that the alterations in myocardial fluid homeostasis may affect
lymphatic system function during cardiovascular disease (3). The heart includes a vast lymphatic
network providing myocardial fluid homeostasis. The lymphatic network proves vital as an
imbalance in fluid due to the difference between myocardial blood microvascular permeability,
and cardiac lymphatic drainage shows a rapid increase in edema with short-term and long-term
complications (3, 8, 20). While it may be tough to establish whether alterations in lymphatic
function causes disease or vice versa, data from the studies mentioned previously continue to
hint at the possible interconnectedness or interdependence of the two systems.
Another factor impacting the lymphatic system function is the net flow of lymph. Two
components determine the net flow rate: lymph formation and lymph propulsion (33, 4).
Systemic forces that drive interstitial fluid into the initial lymphatics determine lymph formation.
An increase in volume of or pressure in the interstitium is among the systemic forces that drive
lymph formation (21). Lymphatic propulsion is the movement of lymph through the previously
discussed components of the lymphatic system back into the circulatory system (33, 4).
Additionally, respiration, blood pressure, exercise, and massage can impact lymph propulsion
through the lymphatics (33). Concerning the mechanisms dictating lymphatic flow,
cardiopulmonary dysfunction would most likely alter the delicate balance of lymph formation
and propulsion. Change in blood pressure would disrupt the balance of hydrostatic pressure and
oncotic pressure on capillaries, causing an increase or decrease in interstitial fluid. An animal
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study by Kneedler that used spontaneously hypertensive rats exhibiting renal injury from
hypertension showed an increase in lymphatic vessel density into the kidney versus the control,
which suggests lymphatic network remodeling in response to renal disease and a change in blood
pressure (16). While this study examines lymphangiogenesis as a potential protective response
by the body to a hypertensive renal system model, with hypertension being the root cause and the
inflammation due to renal injury being another factor, one can speculate that this increased
lymphangiogenesis would facilitate higher filtration of fluids to reduce blood pressure in the
renal system. This response could impact the lymph node structure due to increased lymphatic
vasculature drainage. Perhaps a similar mechanism may be at work for cardiopulmonary failure.
Since renal failure caused by hypertension triggers an inflammatory response causing an impact
on lymphatic vessel formation in the kidney, the same forces then may result in structural
changes to the lymph nodes and their vasculature in the cardiopulmonary region due to
lymphangiogenesis. Studies showing the impact of superior vena cava pressure elevation on
myocardial fluid homeostasis revealed the essential nature of keeping hydrostatic pressure in
check to avoid disruption of lymphatic drainage (20). Another aspect to mention is the vital
importance of heart contraction in lymphatic function. When performing cardiopulmonary
bypass, there was a surprising finding that myocardial lymph flow cessation occurred (20). It
seems too little hydrostatic pressure causes a halt of lymphatic function, which partly leads to
myocardial edema and has a trickle-down effect damaging the heart. In contrast, too much
hydrostatic pressure also yields myocardial edema, which may lead to fibrosis, which indirectly
fosters cardiac damage. A fully functioning cardiac contraction seems crucial to the myocardial
lymphatic function and vice versa. Thus, there seems to be a mutual benefit for two systems in a
normal cardiac state or diseased state to function optimally so that fluid homeostasis can be
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maintained. A disruption in either of the two systems could impact the other. In an otherwise
healthy individual, if lymphatic system failure occurs, the body will need to find a way to rescue
its lymphatic function to prevent cardiac damage caused by lymphatic drainage dysfunction (20).
Unfortunately, the exact mechanism of lymphatic rescue is not fully understood.
Potential association between cardiopulmonary and lymphatic system

When it comes to the lymphatic system, cardiac lymphatics have not received as much
attention as other organ systems' lymphatic systems (3). While there are studies highlighting the
possible association of cardiovascular disease and altered lymphatic function, there has yet to be
more research depicting lymphatic alterations caused by cardiovascular disease (3). This paper
seeks to observe lymphatic system changes in cadavers with cardiovascular disease - notably, the
lymphatic system changes that are apparent between cadavers of a different cause of death. A
study by Laine involving dogs divided into three groups; control, chronic pulmonary
hypertensive with right heart failure, and chronic arterial hypertensive, showed extravascular
fluid increases caused by either elevation of coronary venous pressure or reduction of cardiac
lymph flow were correlated with compromise in cardiac function (17). It further states that a
3.5% increase of extravascular fluid produced a nearly 30 percent reduction of cardiac output at a
left atrial pressure of 15 mm Hg (17). The finding is congruent with the notion that cardiac
lymphatics are vital to maintaining fluid homeostasis and thus the heart's function. The
dysfunctions caused by myocardial edema include systolic, diastolic function, cardiac
arrhythmia, and tissue fibrosis (41). Another interesting aspect to keep in mind is the lymphatic
flow. There are numerous ways to help facilitate lymphatic flow, thus helping remove interstitial
fluid buildup. Edema resolution, as it is called, is affected by the force of contraction of the heart
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and its rate (41). If lymphatic dysfunction starts to negatively affect the heart, it trickles down
and further cripples the edema resolution, exacerbating the worsening lymphatic drainage
process. To combat this effect, there may be attempts by the body to produce stronger heart
contractions in an effort to reduce lymphatic burden and rescue lymphatic function, which can
improve cardiac health.
Studies show pulmonary lymphatics are essential in lung development (32). It seems
during embryonic development, transcription factors and regulatory proteins such as Vascular
endothelial growth factor-C, Prox1, and collagen- and calcium-binding epidermal growth factor
domain-1 are essential in the tyrosine kinase receptor vascular endothelial growth factor
receptor-3 signaling cascade (32). In other words, these proteins are vital for the development of
a fully functioning lymphatic system. The ability to form lymphatics, or lymphangiogenesis, was
altered in mice lacking collagen- and calcium-binding epidermal growth factor domain 1 -/- and
vascular endothelial growth factor receptor-3 kd/kd (kinase-dead), and the mice did not survive
due to respiratory failure after birth (32). This reveals that a compromised development of the
lymphatic system due to a lack in transcription factor and regulatory proteins has led to
respiratory dysfunction, highlighting the importance of a fully functioning lymphatic system in
lung development and function. In another study though, the lymphatic abnormalities were not
concluded as the apparent factor that may have affected abnormal development of lungs, but the
lack of lung lymphatics did seem to result in lowered clearance of interstitial fluid, which
prevented lung tissue expansion (32). Together, these findings seem to support an association of
lymphatic function with lung development or function immediately after birth.
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The interconnectedness of the cardiac and pulmonary systems seems to be gaining
traction as of late. In a study examining chronic obstructive pulmonary disease (COPD) patients
to control, age and sex matched disease-free individuals, it was found that the COPD patients
suffer significantly increased inflammation compared to control (1). Specifically, the researchers
measured a marker for systemic inflammation, C-reactive protein, and compared it to control (1).
The study revealed COPD patients having significant systemic inflammation in addition to
pulmonary inflammation (1). While this may not be the only cause of pulmonary system putting
a strain on the cardiac system, it may be one reason why COPD patients were reported to suffer
from cardiovascular complications (1). Arslan and colleagues report as many as a quarter of
COPD patient deaths were from cardiovascular complications (1). Systemic inflammation, then,
arising from lung dysfunction may be affecting cardiac function negatively. Another aspect to
consider is the potential edema that may be generated because of COPD.
The purpose of the study is to observe the anatomical changes in lymph nodes for
cadavers with cause of death fitting the inclusion criteria for cardiopulmonary disease. While the
exact mechanism is beyond the scope of this paper, it is predicted the anatomical changes may be
partially due to inflammatory factors stimulating B cells, which make up the follicles in the
lymph nodes, as well as systemic forces that drive lymph formation and propulsion.
Additionally, Kneedler et al. demonstrated lymphatic remodeling occurred as an attempt to
rescue function of lymphatic drainage in cases of renal injury, the same may be true for
cardiopulmonary disease. For these reasons, it is hypothesized that the lymph nodes in
individuals with cardiopulmonary disease demonstrate an increase in two-dimensional area
(hyperplasia) as well as an increase in follicle density when viewed under the microscope. A
secondary factor for the alteration may be due to an imbalance in the rate of interstitial fluid

19

leakage from capillaries and the rate of lymphatic drainage due to blood pressure changes. Along
with hyperplasia of lymph nodes, possible signs of lymphangiogenesis may be seen partly due to
the patient's body trying to recompense the inability to drain excess interstitial fluid. As a result,
this could be coupled with visible structural changes revealed via microscope and staining.
Lastly, interleukin-6 levels are expected to be high for cadavers labeled with kidney disease (22,
36). Even though this study will not measure any inflammatory molecules, this could possibility
be the mechanism involved in inflammatory proliferation of B cells. This can also be a future
follow-up for the study. Lastly, increasing evidence points to the relationship between
lymphatics and inflammatory response (7). This is evident in renal transplant rejections as well
(24). For these reasons, a relationship between cardiopulmonary disease, inflammation and
lymphatics was the research point of interest since renal disease has common factors with
cardiopulmonary disease (30).
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METHODS

Cadaver Preparation
The cadavers used for this research were donated to the Philadelphia College of
Osteopathic Medicine (PCOM), Georgia campus. The cadavers' primary use was for anatomical
studies by Physical Therapy students. Throughout the academic year 2020-2021, students
systematically went through the body regions during the cadaver lab for the anatomy class. After
each session, research students under Dr. Shelley DiCecco's guidance extracted nodes from
exposed regions. Out of all the lymphatic structures, lymph nodes became the primary focus of
this research because of the relative ease of extracting lymph nodes from the cadavers.
Extracting lymph nodes that generally range from a few millimeters to a couple of centimeters in
size was more feasible when compared to trying to isolate lymphatic vessels using microscopes
from the cadavers. All research students were initially trained by the lead investigator, Dr.
Shelley DiCecco, to dissect and follow procedures as outlined.
All cadavers for this study were embalmed onsite using an in-house anatomical solution
referred to as the Maryland State Blend (MSB). This blend was prepared by the Hydrol Chemical
Company located in Pennsylvania. This primary solution was first diluted with the addition of
one gallon of water for every ten ounces of MSB before injecting into the cadavers. Per protocol,
a minimum of 4 to 5 gallons of injection are prepped per cadaver to inject over 2 to 3 days. If
needed, an additional 3 to 4 gallons of solution are then prepped and injected until desired
saturation of the vascular system was observed by the Director of Anatomical Donor Services at
PCOM. Per cadaver, roughly 5.6 percent formaldehyde per formalin by volume was added.
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Finally, embalmed cadavers were wrapped with an MSB soaked cotton wrap and plastic wrap
and stored in a zipper pouch. The cadavers were stored in a refrigeration system for 4 to 8
months until needed for anatomical dissections.
Histology Procedures
All the lymph nodes extracted were initially stored in a container with embalming
solution inside. The samples were stored at room temperature. Prior to proceeding on to the next
step, the lymph nodes were removed from the container with embalming solution and transferred
into a container with phosphate buffered saline (PBS) 1X for 24 hours. Afterwards, the lymph
nodes removed from PBS 1X and were processed through Lynx II tissue processor following the
program as outlined step by step: 70% ethanol for 20 min @ 20°C with agitation, 80% ethanol
for 25 min @ 20°C with agitation, 90% ethanol for 25 min @ 20°C with agitation, 95% ethanol
for 25 min @ 20°C with agitation, 100 % ethanol for 25 min @ 20°C with agitation, 100%
ethanol for 40 min @ 20°C with agitation, xylene for 15 min @ 20°C with agitation, xylene for
30 min @ 20°C with agitation, xylene for 60 min @ 20°C with agitation, paraffin for 120 min @
65°C with agitation, and paraffin for 120 min @ 65°C with agitation. This program was a
modified procedure from Ms. Jacquelyn Gerhart at PCOM-PA. Ms. Yan Wu at PCOM-GA has
altered the procedure to fit the conditions of the research lab at PCOM-GA. After the processing
step, the lymph nodes were embedded in paraffin blocks to be sectioned using a microtome. Ms.
Gerhart of PCOM, Philadelphia campus, graciously helped in the tissue sectioning for staining.
Each lymph node was sectioned sagittal for low and mid-section. After the sectioning of the
nodes, each section was stained via the staining process for using hematoxylin and eosin stain
with Gill #3 and eosin y, ethanol solution, 3. Staining times for Hematoxylin and Eosin were 3
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min and 1.5 min respectively for highest contrast as noted per thermoscientific staining
instruction. The structure of each histological section was analyzed qualitatively using EVOS FL
Auto Model AMAFD1000 from Thermofisher.
Cadaver Demographics
The cadavers, ages 58 to 95, of six females and three males were used in the study.
Ethnicities include 8 Caucasians and 1 Indian. Height as well as waist measurements were
obtained per cadaver, which helped calculate the height to waist ratio. Additionally, the cause of
death (COD) was reported per cadaver. To prevent bias, COD was not revealed until all
dissections were completed. COD mainly dealt with issues of cancer, heart disease, and lung
disease. Lastly, lymph nodes were dissected from specific regions of the cadaver. The regions
were: lumbar, common iliac, internal iliac, external iliac, deep inguinal, superficial inguinal,
pulmonary, cardiac, parasternal, infraclavicular, central axillary, pectoral, humeral, subscapular,
anterior neck, lateral neck. Each node was measured in millimeters for length and width. Twodimensional area was calculated for each node.
Inclusion and Exclusion Criteria
For the study, cadavers were separated into two groups based on inclusion criteria for
cardiopulmonary disease. Inclusion criteria included respiratory failure, atherosclerosis heart
disease of native coronary artery, and organic heart disease. Thus, three cadavers were included
in the cardiopulmonary disease COD group. Cadavers excluded from the cardiopulmonary
disease group had COD dealing with different cancer pathologies. These include: brain cancer,
metastatic breast cancer, right lung bronchiogenic carcinoma with local and lymphatic invasion,
glioblastoma, and malignant bone cancer. The reasoning for choosing cardiopulmonary disease
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as the inclusion criteria was the inflammatory response evident in cardiopulmonary disease as
well as the possible increased fluid buildup on the venous end contributing to lymphatic burden
and dysfunction. The study was designed to see the effect of these factors in altering lymph node
structure and size.
Statistical Analysis
Lymph nodes of certain anatomical regions were omitted from analysis if they failed to
meet the minimum number of nodes reported per region of the body by various sources as it may
skew the statistical analysis (Table 1.1.). This was true for not just the analysis pertaining to the
difference in number of lymph nodes but also analysis of two-dimensional area of lymph nodes
as well. Statistical analysis of the recorded data was performed using GraphPad Prism 9. Power
analysis yielded a value of 0.8081. Sample size was not adequate for this research secondary to
an uncontrollable downsize of cadavers due to COVID-19.
Initially, the type of data was identified. Then, normality test was executed to see if data
was normally distributed (Table 1.2.). Various methods of double-check were used such as Q-Q
plot, box and whisker plot, histogram to see if normality test truly captured the behavior of data.
Once this was concluded, nonparametric tests were chosen to be appropriate after concluding
that the data was not distributed normally. For consistency, even when a few data sets were
normally distributed, nonparametric tests were used to allow for comparison between data. Out
of the different nonparametric tests, Mann-Whitney U test was chosen because it was most
appropriate for the type of analysis that needed to be performed (Figure 1.1.). Thus, multiple
Mann-Whitney U tests were performed for comparison of number of nodes, the two-dimensional
area between diseased states, and the height to waist difference between diseased states.
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Histological Analysis
Histological analysis was performed for lymph nodes to see structural deviations between
cadavers with COD as cardiopulmonary disease versus other COD. Hematoxylin and Eosin
(H&E) staining was used on lymph node tissue to view under EVOS Auto FL. Qualitative
assessments were made.
Table 1.1. Minimum number of lymph nodes for inclusion in the study
Nodes

Location

Range of Nodes
Identified/cadaver

Lumbar

Iliolumbar line to L1/L2;
between lumber vertebral
bodies and inferior vena cava
on R and aorta on L. R & L
drain side of body below
diaphragm
From Iliosacral line to
Iliolumbar line; over psoas
muscle
Concavity of Sacrum along
medial and lateral sacral
artery
Along internal iliac arteryinclude lateral sacral and
gluteal nodes
Medial-(In adipose tissue at
obturator fossa) Two
branches- Obturator and
Medial Ext Iliac
Lateral Chain-(Lateral to
External Iliac Artery and on
Psoas) Intermediate- (B/W
Ext Iliac Art and Vein)
Located under femoral fascia
in iliopectineal fossa- along
femoral artery & vein- joins
external inguinal
(Obturator Line divides
upper (trunk) and lower (LE)
inguinal nodes) Subcutaneous
fatty tissue, with the great
saphenous vein. Femoral
Triangle (inguinal ligament,
sartorius muscle,and long
adductor muscle)

Common Iliac

Sacral

Internal Iliac

External Iliac

Deep Inguinal

Superficial
Inguinal

20 to 50

Minimum number
of nodes/cadavers
to be included in
study
20*

Number of
cadavers
meeting
criteria
9

5 to 30

5*

9

2 to 3

2*

0

4 to 18

4*

9

5 to 25

5*

9

1 to 3

1*

9

4 to 25

4*

9
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Parasternal,
Sternal, Inferior
Mammary, or
Thoracica
Internal

Infraclavicular,
Deltoidpectoral,
and/or Apicales
axillary

Central
Axillary

Pectoral,
interpectorals,
sub pectoral, or
anterior axillary

Lateral or
Humeral
axillary

Inner surface of thoracic wall,
along the internal thoracic
vein (usually laterally- yet,
can be medial or both).
Typically in 1-6 intercostal
spaces B. Usually at least 3
cm from margin of sternum.
Covered by transverse
throacic muscle and
endothorax fascia.
Located in the clavipectoral
triangle above the 1st
intercostal space or the 1st
indentation of the anterior
serratus muscle. Embedded in
fatty tissue and covered by
the pectoral muscles and
clavipectoral fascia. Located
at the apex of axilla along
medial side of distal portion
of axillar vein and first
portion of axillary artery. The
deltoidpectoral is 1-2 nodes
beside the cephalic vein,
between pec major and
deltoid below clavicle.
Located in the base of the
axilla, embedded in fatty
tissue and adjacent to the
intercostobrachial nerves.
Usually beneath fascia and
deep to pec minor. Close to
the second portion of the
axillary artery.
Along lateral throacic artery
and vein between 2nd and 6th
or 3rd and 7th ribss. Located
on the medial wall of the
axilla on the anterior serratus
muscle- usually embedded in
a thin layer of adipose tissue
and fascia. Often along
inferior border of pec minor
and/or behind the pec minor.
Interpectoral locared between
pec muslces in the bifurcation
angles of pectoral branch of
the thoracoacromial arterypresent 50% of the time.
Extend from the tendon of the
latissimus dorsi muscle to the
junction of the subscapular
vein with the axillary vein.
Lateral nodes are located on

9 to 18

9*

9

1 to 12

1*

9

1 to 10

1*

9

1 to 14

1*

9

1 to 7

1*

9
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Subscapular or
Posterior
axillary

Pulmonary

Cardiac

the lateral wall, medial and
posterior to axillary veinnear medial cutaneous
brachial nerve.
Located along subscapular
and thoracodorsal vein on the
posterior wall/fold of the
axilla with the upper nodes on
the inferior margin of the
subscapularis muscle. The
lower nodes furrow between
the teres minor and latissimus
dorsi muscles. They do not
have much adipose coverage
and are crossed over by the
intercostobrachial,
subscapular, and
thoracodorsal nerves.
The lymph nodes are located
around the airway, situated
ventral to the periesophageal
nodes and closer to the
venous angle. Main bronchus
nodes are situated in the
proximity of the hilus of the
lungs. Bifurcational nodes are
situated at the bifurcation of
the trachea.
Aortopulmonary window
lymph nodes are located
lateral to the ligamentum
arteriosum, the remnant of the
ductus arteriosus. Para-aortic
lymph nodes lie on the
anterior and lateral aspect of
the ascending aorta and aortic
arch, anterior and/or above
the subaortic lymph nodes

1 to 12

1*

9

5 to 17

5*

9

5 to 12

5*

9

Table 1.1. Minimum number of lymph nodes for inclusion in the study. This table shows
the location of lymph nodes found per different anatomical regions of the body as well as
the typical range of nodes found. A minimum number of lymph node per region of the body
is shown as well as the number of cadavers meeting the criteria. * denotes references
(9,43,44,45,46,47,48).
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Table 1.2. Normality test example using # of lymph node data

Test for normal distribution
D’Agostino & Pearson Test
K2
P value
Passed normality test
(alpha=0.05)?
P value summary
Shapiro-Wilk Test
W
P value
Passed normality test
(alpha=0.05)?
P value summary
Number of values

Cardiopulmonary

Non-Cardiopulmonary

6.055
0.0484
No

3.700
0.1573
Yes

*

ns

0.9277
0.2522
YES

0.8956
0.0815
YES

ns
15

ns
15

Table 1.2. Normality test example using number of lymph node data. This table shows the
test for normal distribution. Distribution of data was assessed to determine the best
statistical tool for the analysis of data sets. * denotes significance. Ns denotes nonsignificance.
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Figure 1.1.

Step by Step diagram of performing statistical analysis

Identifying
what type of
data it is

Testing to see
if data if
normally
distributed
• Is it skewed?

Double - check
distribution via
Q-Q plot,
histogram, or
box plot

Run a
parametric or
nonparametric
test

Figure 1.1
Step by step diagram of performing statistical analysis. This diagram shows the step-bystep diagram of performing statistical analysis. First, data set was assessed for the type of
data. Second, normality test was performed to assess if data was normally distributed or
not. Third, normal distribution was double-checked using q-q plot, histogram, or a boxplot.
Lastly, parametric, or non-parametric test was ran depending on the distribution of data set.
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RESULTS

Height to waist ratio was first analyzed and was not significantly different between
diseased states (cardiopulmonary COD and non-cardiopulmonary COD). A Mann-Whitney U
test was performed to ensure that height to waist ratio per diseased states was not going to factor
in the difference in lymph node size and structure. Next, an examination was completed to see if
there was indeed a difference in the number of lymph nodes found per different regions of the
body when comparing the cardiopulmonary group versus non-cardiopulmonary group (Fig 1.2.).
D’Agostino & Pearson test was performed for each data set and a histogram, Q-Q plot or a box
and whisker plot was examined (Fig 1.3., Fig 1.4., Fig 1.5., Fig 1.6.). The majority of the data
did not qualify as normally distributed data. Therefore, nonparametric tests were used to
compare each data set. Mann-Whitney U test between cardiopulmonary group versus noncardiopulmonary group for the difference in the number of lymph nodes yielded a P value of
0.1035 (Table 1.3). The difference was not significant. To assess for an individual difference in
the different regions, the number of nodes in a specific area, lumbar and cardiac, were looked at.
Mann-Whitney U test yielded a P value of 0.7143. The difference was not significant between
the two groups. The same was done for the cardiac lymph nodes. Mann-Whitney U test yielded a
P value of 0.6905. The difference between the lymph node numbers with or without
cardiopulmonary disease was not significant. All other regions were evaluated, and no significant
differences were noted. In summary, no significant difference existed between the number of
lymph nodes found in cardiopulmonary disease group versus non-cardiopulmonary disease group
for the anatomical regions examined.
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Next, the distribution of two-dimensional area of lymph nodes taken from the lower body
regions were looked at. The lower body regions consisted of lumbar, common, internal iliac,
external iliac, deep, and superficial inguinal. Two-dimensional area between cardiopulmonary
group versus non-cardiopulmonary group was compared per different regions of the body. When
looking at the lumbar region, Mann-Whitney U test yielded a P value of 0.1485 for a one-tailed
test. Looking at the superficial inguinal region, Mann-Whitney U test yielded a P value of 0.4279
for one-tailed test. The cardiopulmonary lymph nodes were not significantly larger than the
counterpart for either the lumbar region or the superficial inguinal region. When comparing all
the other regions, Mann-Whitney U test yielded a nonsignificant value in all the regions except
deep inguinal and internal iliac. Deep inguinal region had a P-value of 0.0146 for one tailed test
and internal iliac region had a P-value of 0.0191 for one tailed test (Table 1.4. and 1.5.).
Afterwards, the distribution of two-dimensional area of upper body regions were examined. The
upper body regions consisted of pulmonary, cardiac, parasternal, infraclavicular, central,
pectoral, and humeral. Mann-Whitney U test revealed that all the regions were not significant in
their differences except the pectoral region. P-value for pectoral region was 0.0111 for a one
tailed test (Table 1.6.). This was the only region with a value significantly larger than the noncardiopulmonary counterpart. In summation, tests of lymph nodes that drain the lower and upper
regions of the body, specifically, the pectoral, deep inguinal, and internal iliac lymph nodes,
revealed a significantly greater two-dimensional area in the cardiopulmonary group than the noncardiopulmonary group.
Lastly, histological assessment of lymph nodes from cadavers with cardiopulmonary
disease and those without was performed. The result was inconclusive. Follicles, and presence of
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germinal centers indicative of B cell proliferation, indicating possible cell proliferation were not
apparent in either group (Fig 1.7.).
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Figure 1.2. # of nodes per region of the body with diagnosis of cardiopulmonary disease
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Figure 1.3. Frequency distribution example using # of nodes
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Figure 1.4. Distribution of two-dimensional area of internal and external iliac nodes with or without
cardiopulmonary disease
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Figure 1.5. Distribution of two-dimensional area of deep inguinal and superficial inguinal nodes with or without
cardiopulmonary disease

36

Figure 1.6. Distribution of two-dimensional area of pulmonary and cardiac nodes with or without cardiopulmonary
disease
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Table 1.3. Mann-Whitney U test – difference in number of nodes with or without cardiopulmonary disease

Table Analyzed

# of nodes

Column A
Vs.
Column B

CP
Vs.
nCP

Mann Whitney U Test
P value
P value summary
Significantly different (P<0.05)?
One- or two-tailed P value?
Sum of ranks in column A,B
Mann-Whitney U

0.1035
ns
No
Two-tailed
193, 272
73

Table 1.3. Mann-Whitney U test – difference in number of nodes with or without
cardiopulmonary disease. This table shows a mann-whitney u test performed for two data
sets comparing the different number of nodes in cadavers with or without cardiopulmonary
disease. CP=cardiopulmonary. nCP=non-cardiopulmonary. Ns denotes non-significant. Twotailed P value indicates that the test looked for a difference in values whether it be an
increase or decrease compared to the other.
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Table 1.4. Mann-Whitney U test – difference in internal iliac node two-dimensional area per diseased state

Table Analyzed

Distribution of Lower body 2 dimensional
area

Column E
Vs.
Column F

Int Iliac CP
Vs.
Int Iliac nCP

Mann Whitney U Test
P value
P value summary
Significantly different (P<0.05)?
One- or two-tailed P value?
Sum of ranks in column E,F
Mann-Whitney U

0.0191
*
Yes
One-tailed
50.50, 102.5
14.50

Table 1.4. Mann-Whitney U test – difference in internal iliac node two-dimensional area
per diseased state. This table shows a mann-whitney u test performed for two data sets
comparing the two-dimensional area of lymph nodes with or without cardiopulmonary
disease in the internal iliac region. CP=cardiopulmonary. nCP=non-cardiopulmonary. *
denotes significance. One-tailed P value indicates that the test looked for a single
directionality in assuming a difference between the two data sets (Either only an increase, or
only a decrease).
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Table 1.5. Mann-Whitney U test – difference in deep inguinal node two-dimensional area per diseased state

Table Analyzed

Distribution of Lower body 2 dimensional
area

Column I
Vs.
Column J

Deep Inguinal CP
Vs.
Deep Inguinal nCP

Mann Whitney U Test
P value
P value summary
Significantly different (P<0.05)?
One- or two-tailed P value?
Sum of ranks in column A,B
Mann-Whitney U

0.0146
*
Yes
One-tailed
265.5, 680.5
129.5

Table 1.5. Mann-Whitney U test – difference in deep inguinal node two-dimensional area
per diseased state. This table shows a mann-whitney u test performed for two data sets
comparing the two-dimensional area of lymph nodes with or without cardiopulmonary
disease in the deep inguinal region. CP=cardiopulmonary. nCP=non-cardiopulmonary. *
denotes significance. One-tailed P value indicates that the test looked for a single
directionality in assuming a difference between the two data sets (Either only an increase, or
only a decrease).
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Table 1.6. Mann-Whitney U test – difference in pectoral node two-dimensional area per diseased state

Table Analyzed

Distribution of Upper body 2 dimensional
area

Column K
Vs.
Column L

Pectoral CP
Vs.
Pectoral nCP

Mann Whitney U Test
P value
P value summary
Significantly different (P<0.05)?
One- or two-tailed P value?
Sum of ranks in column K,L
Mann-Whitney U

0.0111
*
Yes
One-tailed
61, 215
25

Table 1.6. Mann-Whitney U test – difference in pectoral node two-dimensional area per
diseased state. This table shows a mann-whitney u test performed for two data sets
comparing the two-dimensional area of lymph nodes with or without cardiopulmonary
disease in the pectoral region. CP=cardiopulmonary. nCP=non-cardiopulmonary. * denotes
significance. One-tailed P value indicates that the test looked for a single directionality in
assuming a difference between the two data sets (Either only an increase, or only a
decrease).
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Figure 1.7. Histology of pulmonary lymph node with or cardiopulmonary without disease

A

B

Figure 1.7. Histology of pulmonary lymph nodes with or without cardiopulmonary disease.
Shown above is a histology of pulmonary lymph nodes with or without cardiopulmonary
disease. Scale is 10X or 400 um. A shows a mid-section of non-cardiopulmonary lymph node
from a pulmonary region. B shows a mid-section of a cardiopulmonary lymph node from a
pulmonary region.
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DISCUSSION

The results gathered from statistical analysis were surprising in several ways. First, the
difference in number of lymph nodes in cardiopulmonary group versus non-cardiopulmonary
group was statistically not significant (Table 1.3.). While literature does not report a difference in
the number of lymph nodes in individuals with cardiopulmonary disease, several cadavers in the
non-cardiopulmonary group COD involved cancer. Even though individuals with cancer often
undergo biopsy and/or lymphadenectomy as part of treatment the results did not show a
significant difference. Secondly, if patients suffering from cardiopulmonary disease indeed had
some inflammation as compared to non-cardiopulmonary involvement one would expect to find
increased signs of follicles when viewing histology. However, this was not the case.
Unfortunately, most qualitative assessments were inconclusive as structures seemed disrupted at
best for both groups. Therefore, the study is unable to state that the cardiopulmonary group may
have suffered from cardiopulmonary disease at the lymphatic structural level. Lastly, the regions
showing statistical significance in the size difference included the deep inguinal, internal iliac
and pectoral region. The anticipated areas of difference were the pulmonary and cardiac nodes.
The explanation for the results with differences in the two-dimensional area is not clear.
However, there are possible explanations for why deep inguinal and internal iliac lymph nodes
may have been larger. In cardiopulmonary diseased state, there is a potential increased venous
end fluid buildup. This may have resulted in lower extremity lymph nodes needing to drain more
fluid as compared to the non-cardiopulmonary disease group. For the pectoral lymph nodes, an
increase in fluid near the heart due to cardiopulmonary disease may have led to an increase in
drainage load by the pectoral node. It may be beneficial to perform additional research looking at
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all these factors with a larger sample size to fully evaluate significance of the relationship
between cardiopulmonary disease and the lymphatic system.
A significant limitation out of control of the research team involved the state of the
cadaveric regions for node retrieval. Since the cadavers were for anatomical dissections for
Physical Therapy (PT) students' educational use, dissections for research occurred after each
anatomy class. The dissections into new parts only began after the PT students exposed certain
anatomical regions. While both the dissection team and the PT students were trained by Dr.
Shelley DiCecco to look for lymph nodes and extract them, lymph nodes may have been excised
or lost due to inexperience. Each cadaver had randomized research members dissecting it due to
the possibility of variance in dissection skill skewing lymph node extraction. Some of the regions
may be shy of reaching the minimum number of nodes reported in a specified area due to reasons
mentioned above and/or unknown past surgical history. In addition, due to COVID-19, less
cadavers were available for dissection. The previous year, there were a total of 43 cadavers to
look at as opposed to this year, there was only a total of 9 cadavers to examine. Lastly, the
anatomical regions for lymph nodes were omitted from statistical analysis if they failed to meet
the generally reported minimum number of nodes to minimize statistical errors (9).
Another limitation of the study is the difference in weight of the cadavers. Most of the
cadavers were visibly overweight. Thus, drawing an association between cardiopulmonary
disease and its effect on the lymph nodes is tricky because it has been reported over the last few
years that obesity may be associated with acquired lymphatic dysfunction. To account for this
fact, height and waist measurements were obtained per cadaver and height to waist ratio
calculated. In a study by Weitman and colleagues, a nonparametric test concluded that the
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difference between an experiment using diet-induced obese mice versus lean mice showed a
decreased ability to clear interstitial fluid and decreased trafficking of inflammatory molecules to
lymph nodes (40). Histological analysis of lymph nodes revealed that obese mice had an
abnormal distribution of B cell and T cells with loss of follicle organization compared with
control (40). Loss of CCL21 expression in the obese group may have resulted in the
disorganization of B and T cells as the control group shows CCL21 expression predominantly in
the T cell zones, or equivalently, the paracortex of lymph nodes (40). Thus, for cadavers with
higher weight compared to their height, it may prove difficult to conclude that the changes seen
histologically may only be from cardiopulmonary disease. Finally, it is also important to note
that in obesity, inactivity may be factor which may lead to increased edema in patients. This can
also have an impact in increased load of lymphatic drainage in the lower extremities that could
potentially affect the structure and size of lymph nodes in the lower body regions.
Consistent with findings showing obesity and acquired lymphatic dysfunction altered
histological structure of lymph nodes, using lymphedema model mice group, Savetsky showed
obese mice demonstrated decreased lymphatic function compared to the lean mice with or
without lymphatic injury (27). Additionally, there was a marked increase in response to
inflammation in the obese mice as compared to lean mice with as much as threefold for CD45+
cells and two and a half fold for CD4+ cells (27). CD4+ cells are involved in inflammation in
lymphedema and are crucial in the lymphatic regeneration process and the mediation of
lymphatic function (27). Furthermore, an increased CD4+ cell inflammation in the obese mice
with lymphedema would lead to increased fibrosis, like the response post lymphatic injury,
potentially leading to additional reduction in lymphatic function (27).
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A study by Keshavarz and colleagues involving axillary lymph nodes and the effect of
obesity on the structural deviation of lymph nodes found the ratio of hilo-cortical regions and
lymph node length increased except for cortical width (15). This result may explain the worse
prognosis for overweight breast cancer patients as the immune response and function are
implicated with the cortex of lymph nodes (15). Altogether, the acquired lymphatic dysfunction
resulting in a possible increase in inflammation and abnormal fibrosis must also be considered
for when concluding an association between cardiopulmonary disease’s impact on lymph node
size and structural changes in cadavers with higher weight.
The third limitation of the study could be the aging of the lymph node when evaluating
lymph node histological changes. Traditionally, the lymph nodes include a cortex with primary
and secondary follicles, a paracortex, and a medulla (11). Each compartment includes T- and Bcells, stroma cells, dendritic cells, and macrophages (11). A decrease in T cell population has
been noted in aging lymph nodes in mice. B cells, on the other hand, were shown to maintain
their population in aging mice. Another important note was the disruptions in follicular regions
with less defined features when comparing young mice to aged mice (37). No changes were
observed in subcapsular sinus macrophages' ability to capture harmful pathogens or its ability to
deliver the antigen containing immune complex to B cells (37). B cells' ability to uptake the
immune complex was not altered (37). However, the retention of the immune complex by
follicular dendritic cells was decreased significantly in aged mice, which suggests a decline in
the ability to maintain immune response and mediate germinal center growth (37). Another study
observing superficial inguinal nodes extracted during pathological forensic autopsies revealed
the regions undergoing generalized degeneration due to age made demarcations of the B and T
zones harder (11). Therefore, it may not be possible to draw definitive conclusions on the
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association between the effect of cardiopulmonary disease on lymph node size and structural
changes per antigen components in germinal centers as the age of the cadaver may be a limiting
factor. However, as cardiopulmonary disease is typically diagnosed in the older population an
increase in germinal centers observed in older cadavers may hint at the effect of
cardiopulmonary disease in structural changes of lymph nodes. Additionally, any characteristic
differences in unclear demarcations of B and T zones must also be noted.
The fourth limitation of the study may be the possible co-morbidity of cadavers. While
the primary cause of death per cadaver is listed, other possibly important medical history is
missing. One example is nutritional state. A review article by Cesta discusses the decrease of
lymphocytes observed in patients receiving total parenteral nutrition (5). Of course, this affected
the gut-associated lymphoid tissue, and Cesta mentions reversal when re-initiating enteral
feeding. However, this fact does not undermine the importance of diet as a factor that may
contribute to changes in the number of lymphocytes observed in this cadaveric study. Since it is
not readily available what impact the nutritional state the cadavers were in before death, it
remains difficult to draw any conclusive statements without diet being a potential confounding
variable. Another example is if cancer was a co-morbidity and not the main COD. There is no
way to know if the changes occurred due to cancer or cardiopulmonary disease. For the longest
time, many researchers thought increased lymph node size was due to cancer. This of course, is
not the case as inflammation has also been shown to contribute to alterations of lymphatic
structure. Thus, conclusive statements are harder to make given a detailed history of the patient
was not provided.
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The fifth limitation of the study may be sex differences between cadavers. For
cardiopulmonary disease group, there was 1 male and 2 females whereas the noncardiopulmonary group had 2 males and 4 females. Although the ratio of males to females was
not too skewed between the groups to compare for cardiopulmonary group versus noncardiopulmonary group, it would not have been a stretch to make a statement that the differences
seen in deep inguinal two-dimensional area may have been impacted by the sex differences.
After all, sex differences of cadavers are a confounding variable in this study. It is well known
that females and males have hormonal differences as well as structural differences, especially in
the pelvic region. Perhaps, the different reproductive organ development between genders and
thus the sex differences in the pelvic regions of the cadavers might have contributed to the
difference in two-dimensional area of the deep inguinal lymph nodes. The reasoning would be
that there would be a difference in the lymphatic drainage required by males versus females that
would respectively require an adaptation by the impacted lymph nodes.
Additional studies with a larger sample size would be beneficial for the medical
community to see the possible impact of cardiopulmonary disease on the changes with both the
local lymphatic nodes and the entire lymphatic system. In particular, the lymphatic vasculature
and its dysfunction can be a future study to complement this research's findings. Currently,
radionuclide lymphoscintigraphy using Technetium 99 injected sub-dermally is a popular
method for assessing lymphatic function (6). For future research, it may be interesting to see the
progression of lymphatic dysfunction in diseased state utilizing this technique. Additionally, a
time-dependent change observed in the lymphatic system may provide clues to mitigate or lessen
the impact of diseased states on lymphatic dysfunction. A significant limitation with this
technique is it can only assess the level of Technetium uptake by lymphatics and its function, not
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the possible anatomical changes of the lymphatic vessels due to its poor resolution (6).
Therefore, the research design would need complementary methods to investigate the exact
mechanism contributing to the dysfunction. Additionally, the potential of regulating lymphatic
vessels via targeting the autonomic nervous system may be beneficial in the treatment and/or
prevention of lymphatic changes (2). Previous research confirmed that neurotransmitters directly
target lymphatic endothelial cells, and nerves are closely associated with lymphatic vessels (2).
A study assessing the involvement of α1 – adrenergic and muscarinic agents on lymphatic vessel
contractility in vivo revealed there is an ability to modulate the lymphatic vessel's function (2).
There may be potential benefits to those with cardiopulmonary disease with the use of α1 –
adrenergic and muscarinic agents. Theoretically, improved contractility of lymphatic vessels may
help lessen the drainage burden and improve the cardiopulmonary system's overall function.
However, unless the treatment is specified and the target is selective, the treatment plan using
adrenergic and muscarinic agents on lymphatic vessel may be difficult. It may lead to unintended
side-effects such as contraction of smooth muscles, increase in secretion of exocrine glands, and
slowing of heart rate via muscarinic agents and the activation of the sympathetic nervous system
via adrenergic agents resulting in an increase in heart rate, muscular contraction, and pupil
dilation to name a few.
Another suggestion for future research would be to look at the inflammatory molecules.
The inflammatory molecules released during kidney dysfunction are known to impact lymphatic
structure. Looking to see if the same inflammatory molecules are playing a role in patients with
cardiopulmonary disease might prove beneficial. In Castleman's disease (CD), characterized by
lymph node enlargement, interleukin-6 (IL-6) has been tied to potentially stimulating the
proliferation of B cell lymphocytes and is expressed in CD tissues (25). Previously, there was a
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tendency to link enlarged lymph nodes to cancer metastasis. However, it is not the only cause, as
studies have revealed that factors such as inflammatory molecules may be the contributing factor
of lymph node hyperplasia (31). Vascular endothelial growth factor C and its role in
lymphangiogenesis in the kidney may also be of potential interest in the cardiopulmonary
diseased state (16). Future research incorporating immunochemistry of IL-6 and vascular
endothelial growth factor C may provide more insight into the role of these biomolecules in the
event of cardiopulmonary failure and their link in alterations of lymphatic structure and function.
Lastly, it might be possible to determine if lymphotoxin α as well as lymphotoxin β
receptors play a role in changes to lymphatic structure in renal injury and cardiopulmonary
disease (14, 29). Lymphotoxin α, β is a lymphokine and they are under the tumor necrosis factor
(TNF) superfamily (29). They are important in the regulation of growth and function of
lymphocytes. Current research highlights the importance of lymphotoxin α, β and LTβR. Micedeficient in lymphotoxin α, β and LTβR are shown to have abnormal development of lymph
nodes and peyer’s patch (14, 29). Additionally, mice deficient in lymphotoxin α also show defect
in germinal center formation, follicular dendritic cell network, and T and B cell segregation in
the spleen (14). For these reasons, it may be interesting to see if there are possible changes to
lymphotoxins and its mechanism of action that may alter lymphatic structure in renal injury and
cardiopulmonary disease.
In addition to looking at the inflammatory molecules, observing changes occurring at the
cellular level should be considered with future research. When lymph enters the lymph node
initially into the subcapsular sinus site, lymphatic fluid undergoes screening. The macrophage at
this location, referred to as the subcapsular sinus macrophage, captures the antigens or pathogens
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that arrive at this location to form a complex containing the antigen (37). This complex is known
as major histocompatibility complex, or MHC (42). This complex then relays this antigencontaining immune complex to nearby B cells. When the antigen is processed inside the B cell,
MHC class II proteins binds to the processed antigen and together, it is displayed on the surface
of the B cell (42). Helper T cells bind to the antigen on the surface of the B cell and releases
cytokines (42). The cytokines stimulate the B cells to proliferate and divide into more copies of
itself (42). The B cells, then differentiate into either an antibody producing plasma cell or
memory cell (42). The B cells also migrate to the nearby follicular dendritic cells within the
follicles (37). The follicular dendritic cells take in the immune complex and increase the immune
complex's expression, causing germinal centers to form and initiate an adaptive immune
response. For this reason, it is speculated that in cadavers with the cardiopulmonary disease as
the cause of death, lymph node histology may reveal a disruption in the structure as an effect.
Furthermore, combining this knowledge with current research exploring lymphatic alterations
leading to cardiopulmonary disease will help narrow the difference between this paper's findings
to see how a diseased state further affects the lymphatic system changes.
Increasing knowledge of lymphatic markers and new technology have opened new doors
for the lymphatic system. More studies reveal the lymphatic system and its changes in different
conditions due to an increased ability to differentiate between vascular endothelial cells and
lymphatic endothelial cells. Additionally, therapeutic approaches involving lymph nodes such as
intranodal vaccinations and lymph node transplantation are now an interest (2). Therefore, it is
necessary to continue research that observes the lymphatic system and its changes caused by
different factors. While this study contains qualitative analysis and statistical significance in the
changes occurring in the lymphatic system due to cardiopulmonary disease, further research
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complementing this research using immunohistochemistry may provide added power needed to
make conclusive remarks regarding the potential changes. Hopefully, with the findings from this
research, more research will be done with additional emphasis into the effect of different
diseased states on the lymphatic system. This research and the subsequent research could help
guide future medical treatment plans and research into new therapy targets, including the
lymphatic system. Lastly, the need to see how diseased states impact the lymphatic system is
necessary in improving patient’s quality of life (QOL). It is reported that quality of life continues
to depreciate from the moment patient develops lymphatic disease to when the patient is
diagnosed with lymphatic disease. Patients complain of pain, discomfort, inability to find proper
clothing, and other quality of life impacting symptoms (6). Early detection is, therefore, crucial
to prevent the rapid acceleration of lymphatic disease (35). Therefore, utilizing the correct
disease progression tool will help detect early signs that may prevent or slow down the disease
progression (35).
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